Cue Biopharma Inc. (CUE)
NASDAQ: CUE
· Real-Time Price · USD
0.82
0.03 (3.80%)
At close: Aug 15, 2025, 3:39 PM
Cue Biopharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2.95M | 421K | 1.58M | 3.34M | 2.66M | 1.72M | 1.82M | 2.1M | 1.38M | 187K | 151.23K | 68K | 26K | 1M | 8.25M | 2.4M | 2.74M | 1.55M |
Cost of Revenue | 100K | n/a | n/a | n/a | n/a | 849K | 851K | 35.52M | 848K | 880K | 580.05K | 539K | 458K | 229K | 6.69M | 11.29M | 8.76M | 9.82M |
Gross Profit | 2.85M | 421K | 1.58M | 3.34M | 2.66M | 1.72M | 970K | -33.42M | 534K | -693K | -428.83K | -471K | -432K | 771K | 1.57M | -8.89M | -6.02M | -8.26M |
Operating Income | -8.63M | -12.3M | -9.63M | -8.81M | -10.38M | -12.67M | -13.68M | -11.42M | -13.52M | -13.38M | -14.87M | -11.03M | -13.09M | -14.24M | -7.89M | -13.02M | -10.3M | -12.52M |
Interest Income | 198K | 170K | 290K | 343K | 427K | 562K | 905K | 700K | 564K | 641K | 632.24K | 200K | 88K | 8K | 3.9K | 25K | 24K | 13K |
Pretax Income | -8.48M | -12.26M | -9.5M | -8.66M | -10.17M | -12.35M | -13.43M | -11.01M | -13.19M | -13.11M | -14.59M | -10.96M | -13.21M | -14.26M | -7.89M | -12.99M | -10.28M | -12.51M |
Net Income | -8.48M | -12.26M | -9.5M | -8.66M | -10.17M | -12.35M | -13.43M | -11.01M | -13.19M | -13.21M | -14.45M | -10.88M | -13.33M | -14.27M | -8.38M | -12.99M | -10.28M | -12.51M |
Selling & General & Admin | 3.67M | 4.17M | 4.02M | 2.87M | 3.51M | 3.34M | 3.86M | 3.65M | 4.25M | 4.18M | 3.7M | 3.53M | 3.78M | 5.16M | 4.73M | 4.1M | 4.28M | 4.25M |
Research & Development | 7.82M | 8.55M | 7.18M | 9.38M | 9.53M | 10.2M | 10.79M | 9.87M | 10.65M | 9.39M | 11.33M | 7.57M | 9.59M | 10.08M | 11.5M | 11.29M | 8.76M | 9.82M |
Other Expenses | n/a | n/a | 4K | n/a | n/a | 849K | n/a | -857K | n/a | n/a | n/a | n/a | n/a | n/a | -25K | 25K | n/a | n/a |
Operating Expenses | 11.49M | 12.72M | 11.21M | 12.25M | 13.04M | 14.38M | 14.64M | 12.66M | 14.9M | 13.57M | 15.04M | 11.1M | 13.37M | 15.24M | 16.15M | 15.41M | 13.04M | 14.07M |
Interest Expense | 45K | 128K | 153K | 188K | 215K | 241K | 507K | 286K | 232K | 370K | 358.81K | 124K | 206K | 25K | 1K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -849K | -751K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 11.59M | 12.72M | 11.21M | 12.15M | 13.04M | 14.38M | 15.5M | 13.52M | 14.9M | 13.57M | 15.04M | 11.1M | 13.37M | 15.24M | 16.15M | 15.41M | 13.04M | 14.07M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 99K | -138.43K | -76K | 118K | 17K | 495K | 2K | n/a | n/a |
Shares Outstanding (Basic) | 95.46M | 74.25M | 74.24M | 51.23M | 50.17M | 49.47M | 47.14M | 46.36M | 44.8M | 44.65M | 39.17M | 35.38M | 35.36M | 32.64M | 31.52M | 31.32M | 31.23M | 30.43M |
Shares Outstanding (Diluted) | 95.46M | 74.25M | 74.24M | 51.23M | 50.17M | 49.47M | 47.14M | 46.36M | 44.8M | 44.65M | 39.17M | 35.38M | 35.36M | 32.64M | 31.52M | 31.32M | 31.23M | 30.43M |
EPS (Basic) | -0.09 | -0.17 | -0.13 | -0.17 | -0.2 | -0.25 | -0.28 | -0.24 | -0.29 | -0.3 | -0.37 | -0.31 | -0.38 | -0.44 | -0.27 | -0.41 | -0.33 | -0.41 |
EPS (Diluted) | -0.09 | -0.17 | -0.13 | -0.17 | -0.2 | -0.25 | -0.28 | -0.24 | -0.29 | -0.3 | -0.37 | -0.31 | -0.38 | -0.44 | -0.27 | -0.41 | -0.33 | -0.41 |
EBITDA | -8.34M | -11.25M | -9.34M | -7.59M | -9.09M | -11.26M | -12.08M | -9.86M | -12.11M | -11.86M | -13.65M | -10.29M | -12.54M | -14M | -9.83M | -12.68M | -9.96M | -12.19M |
EBIT | -8.44M | -12.13M | -9.34M | -8.47M | -9.96M | -12.11M | -12.93M | -10.72M | -12.95M | -12.74M | -14.23M | -10.83M | -13M | -14.23M | -7.89M | -12.99M | -10.28M | -12.51M |
Depreciation & Amortization | 100K | 882K | 98K | 879K | 866K | 849K | 851K | 857K | 848K | 880K | 580.05K | 539K | 458K | 229K | -2.73M | 316K | 314K | 318K |